Reports for AMGEN CANADA INC

Company Name

AMGEN CANADA INC

Totals

Shortage reports

4

Actual shortage: 0 (0%)
Anticipated shortage: 0 (0%)
Avoided shortage: 0 (0%)
Resolved: 4 (100%)

Discontinuation Reports

4

To be discontinued: 1 (25%)
Discontinued: 3 (75%)
Reversed: 0 (0%)

Late reports

0 (0%)

Overdue reports

1 (100%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
NEUPOGEN 300MCG SOLUTION Resolved 2025-02-17 2025-03-25 250477
SENSIPAR 30MG TABLET Resolved 2024-06-11 2024-09-18 230090
SENSIPAR 60MG TABLET Resolved 2024-06-11 2024-09-18 230105
SENSIPAR 90MG TABLET Resolved 2024-06-11 2024-09-18 230112

Showing 1 to 4 of 4

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
REPATHA 120MG SOLUTION To be discontinued 2024-03-26 2025-01-06 223420
SENSIPAR 30MG TABLET Discontinued 2024-09-18 2024-09-18 237894
SENSIPAR 60MG TABLET Discontinued 2024-09-18 2024-09-18 237897
SENSIPAR 90MG TABLET Discontinued 2024-09-18 2024-09-18 237900

Showing 1 to 4 of 4